Get started
Author

Jonathan Siglin

Immune effector cell–associated neurotoxicity syndrome after chimeric antigen receptor T-cell therapy for lymphoma: predictive biomarkers and clinical outcomes
2020 · Noa G Holtzman, Hao Xie, et al. · Neuro-Oncology · 119
Astrocytes from the brain microenvironment alter migration and morphology of metastatic breast cancer cells
2017 · Marina A. Shumakovich, Caitlin P. Mencio, et al. · The FASEB Journal · 47
Chimeric antigen receptor T‐cell therapy after allogeneic stem cell transplant for relapsed/refractory large B‐cell lymphoma
2020 · Forat Lutfi, Noa Holtzman, et al. · British Journal of Haematology · 24
PDF
Incidence of Postoperative Opioid Overdose and New Diagnosis of Opioid Use Disorder Among US Veterans
2020 · Jonathan Siglin, John D. Sorkin, et al. · American Journal on Addictions · 24
Postoperative opioid misuse in patients with opioid use disorders maintained on opioid agonist treatment
2019 · Khodadad Namiranian, Jonathan Siglin, et al. · Journal of Substance Abuse Treatment · 16
Deep dissection of the antiviral immune profile of patients with COVID-19
2021 · Djordje Atanackovic, Stephanie V. Avila, et al. · Communications Biology · 11
PDF
The incidence of persistent postoperative opioid use among U.S. veterans: A national study to identify risk factors
2020 · Khodadad Namiranian, Jonathan Siglin, et al. · Journal of Clinical Anesthesia · 11
Pseudo-Allogeneic CAR-T Therapy after Allogeneic Stem Cell Transplantation in Relapsed/Refractory B-Cell NHL
2020 · Jonathan Siglin, Forat Lutfi, et al. · Blood · 6
Mycobacterium szulgai pulmonary infection in a woman with anorexia nervosa
2020 · Kamini Shah, Jonathan Siglin, et al. · IDCases · 3
PDF
Successful Treatment of Delayed Localized Necrotizing Inflammatory Myositis After Severe Acute Respiratory Syndrome Coronavirus 2 mRNA-1273 Vaccine: A Case Report
2022 · Jennifer Chen Li, Jonathan Siglin, et al. · Open Forum Infectious Diseases · 2
PDF
The Impact of Bridging Therapy Prior to CAR-T Cell Therapy on Clinical Outcomes of Patients with Relapsed Refractory Large B-Cell Lymphoma
2020 · Forat Lutfi, Ankit Kansagra, et al. · Blood · 2
Detailed Immunophenotypic Profiling of Peripheral Blood Immune Cells in Patients with Hematologic Malignancies after Sars-Cov-2 Infection
2020 · Forat Lutfi, Jonathan Siglin, et al. · Blood · 2
The Impact of Bridging Therapy Prior to CAR-T Cell Therapy on Clinical Outcomes of Patients with Relapsed Refractory Large B-Cell Lymphoma
2021 · Forat Lutfi, Ankit Kansagra, et al. · Transplantation and Cellular Therapy · 1
A Break in the Case: an Exercise in Clinical Reasoning
2024 · Jonathan Siglin, Daniel Restrepo · Journal of General Internal Medicine
PDF
Immunophenotypic Profiling of Immune Cells in Patients with and without Hematologic Malignancies Affected By Sars-COV-2 Infection
2021 · Gabriela Sanchez-Petitto, Forat Lutfi, et al. · Transplantation and Cellular Therapy
Updates in Chimeric Antigen Receptor T-Cell (CAR-T) Therapy for Lymphoma and Leukemia from the Annual Meeting of American Society of Hematology 2019
2020 · Ali Bukhari, Jonathan Siglin, et al. · Critical Reviews in Oncology/Hematology
C-reactive protein: not always a reliable marker of ongoing cytokine release syndrome in CAR-T therapy following IL-6 blockade
2020 · Jonathan Siglin, Ali Bukhari, et al. · Leukemia & lymphoma/Leukemia and lymphoma
Works count: 17
Citation count: 268
H-index: 7
I10-index: 7
Year
Topic
Type